Guru Ownership Trend
Guru Analysis for DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC), a key player in the 醫療健康 sector, continues to attract institutional attention.
As of Q3 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $28.55 M.
Top institutional holders include 萊昂·庫珀曼 and 私募資本.
Institutional sentiment is currently Neutral. Capital flow remained balanced this quarter with no significant net changes.
Recent activity highlights 私募資本 who opened a new position.
Key Holders
Recent Activity Breakdown (Q4 2025)
+$0
Total Buy Value
New Buys
0
Additions
0
-$0
Total Sell Value
Reductions
0
Sold Out
0
Guru Consensus (Q4 2025)
Based on recent activity
Net Sellers
0
Net Buyers
0
FAQs for DiaMedica Therapeutics Inc. (DMAC)
No tracked managers reduced or fully exited their positions in DMAC during the most recent reporting period.
No tracked managers opened new positions or increased their holdings in DMAC during the most recent reporting period.